Revelation Biosciences, Inc. (REVB) has a market capitalization of $4.46M and trades at $1.20. The 52-week range is 1.06-44.772.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-23.95.
The stock has a beta of -0.17, operates in the Healthcare sector.
